T cells modulate the development and maintenance of painful paclitaxel-induced peripheral neuropathy in RNU rats

Keyphrases

• T Cells 100%
• Paclitaxel-induced Peripheral Neuropathy 100%
• Paclitaxel 33%
• Natural Killer Cells 11%
• CD4+ 11%
• Peripheral Neuropathy 11%
• CD8+ 11%
• Sciatic Nerve 11%
• M2 Macrophages 11%
• Cold Sensitivity 11%
• Tumor Cells 5%
• B Cells 5%
• Immunohistochemistry 5%
• Biological Factors 5%
• Genetic Background 5%
• Gait 5%
• Cancer Model 5%
• Adult Male 5%
• Burrow 5%
• Spleen 5%
• Pain Behavior 5%
• Chemotherapy-induced Peripheral Neuropathy 5%
• Total Dose 5%
• Flow Cytometry 5%
• Cell Count 5%
• CD11b 5%
• Macrophage Polarization 5%
• Complex Role 5%
• CD86 5%
• Lymphocyte Subsets 5%
• Pain Intensity 5%
• Reflexive 5%
• Cell Ratio 5%
• Hormonal Status 5%
• Background Modeling 5%
• CD68 5%
• T Cell Balance 5%
• CX3CR1 5%
• CD45RA 5%
• Experimental Factors 5%
• Cell Reduction 5%
• Mechanical Hypersensitivity 5%
• Intraperitoneal Paclitaxel 5%
• CD206 5%
• M1 Phenotype 5%
• Macrophage Populations 5%
• Therapeutic Development 5%
• Soluble CD163 (sCD163) 5%
• Reflexible 5%

Immunology and Microbiology

• T Cell 100%
• Rowett Nude Rat 100%
• Rat 35%
• Natural Killer Cell 11%
• Cytotoxic T-Cell 11%
• CD4 11%
• Sciatic Nerve 11%
• Hypersensitivity 11%
• Cold Sensitivity 11%
• Macrophage 5%
• B Cell 5%
• Tumor Cell 5%
• Gait 5%
• Cell Count 5%
• CD86 5%
• Genetic Background 5%
• Lymphocyte Subpopulation 5%
• CX3CR1 5%
• CD68 5%
• CD163 5%
• M2 Macrophages 5%
• CD3 Antigen 5%
• Macrophage Polarization 5%